Chapter 134 - Mesenteric artery dissection Flashcards
Spontaneous isolated SMA dissection first described
Bauersfeld 1947
Current number of spontaneous isolated SMA (SISMAD) and celiac (SICAD) dissections
SISMAD 622 cases SICAD 100 cases concomitant 13 cases
Epidemiology of SISMAD/SICAD
67-88% in men 50’s to 60’s age HTN in 30-40% of patients only Majority of cases in Korea, China, Japan
Etiology of SIVAD
1) connective tissue disease (Marfan’s, Ehlers-Danlos, Loeys-Diez) 2) cystic medial necrosis 3) segmental arteriole mediolysis 4) Bechet 5) FMD 6) smoking 7) atherosclerosis 8) ETOH 9) obesity 10) heavy lifting 11) pregnancy majority of SIVAD do not have any of these
Anatomy of the SISMAD
1-3 cm from SMA ostium SMA transition from fixed retropancreatic position with acute turn into mobile mesenteric root
SISMAD genetic chromosomal link
locus 5q13-14 linked to familial ascending aortic aneurysm and dissection
Symptoms of SIVAD
1) abdominal pain 90% (mid-epigastric radiation to back) 2) nausea vomiting 3) melena, diarrhea
Sakamoto classification of SISMAD 2007 Zerbib added TYPE 5
Classify based on CT appearance TYPE 1: patent false lumen with entry + reentry TYPE 2: cul-de-sac false lumen without reentry TYPE 3: thrombosed false lumen with ulcer TYPE 4: thrombosed false lumen without ulcer TYPE 5: aneurysmal dissection with stenosis distally TYPE 6a: total thrombosis of SMA TYPE 6b: partial thrombosis of SMA
Yun classification of SISMAD
TYPE 1: patent true and false lumen with entry and re-entry sites TYPE 2a: patent true lumen with no reentry site but patent FL TYPE 2b: patent true lumen with no reentry site but thrombosed FL TYPE 3: occluded SMA
Luan classification
TYPE A: dissection at curve of SMA to SMA ostium TYPE B: dissected limited to curve of SMA TYPE C: extending from curve down distally but not to the ileocolic or distal ileal TYPE D: towards ileocolic/ileal artery
Goal of stenting in SIVAD
1) eliminate stenosis of false lumen encroachment 2) stabilization of vessel integrity to avoid late degeneration
Indication for SMA stenting in SISMAD
1) stenosis > 80% 2) dilation > 2cm
Medical treatment of SISMAD with anticoagulation or antiplatelet
no good evidence for either
SISMAD treatment algorithm
FIGURE 134.7
Surveillance of SIVAD
Imaging 1 month then 6 months x 1 year then annually